About
About Me
Building Solid Ventures around Products with High Patient Value
I am a strategic leader able to drive the growth of medtech companies and products that make a significant positive difference in people's lives.
In everything I do, I combine the rigorous thinking and analytical methodology from my natural sciences background with the long-term vision of a founder mindset and the skills of a process and organization-oriented, leader and board member.
In my seven years of board membership, I have worked with top MedTech leaders in robotic surgery, neuromodulation and regenerative medicine, balancing the needs and interests of all corporate stakeholders. I am a proven team-builder and team-player, unafraid of taking on new challenges.
In my founder experience, starting from an original idea, I was instrumental in delivering a unique new robotics product to hospitals in a company that grew to one hundred employees in 6 years. In the course of this I secured capital of over EUR 40M from Angel investors, VC funds and non-dilutive funding, from initial outreach and pitches through term sheets, due diligence, investment docs and closings. My passions are strategically building products and companies by identifying clinical needs that represents a unique market opportunity using a strong data-backed approach.
I have driven product development and company growth while working hand-in-hand with the community of physician and patient end-users. I am a German and US national and have lived and worked in California, Germany, Great Britain and Italy, gaining a unique multicultural experience allowing me to work effectively with teams internationally.
Key Achievements
Surgical Robotics
-
Co-founder, Board Member and VP Clinical Development & Medical Affairs at MMI Inc. until Nov. 2021.
-
Instrumental in defining product-market fit and validating it with the user community.
-
Hired and lead a team of Clinical Engineers to drive MMI's product development from a Clinical standpoint, coordinating with surgeon end-users on product specifications, device validation and definition of clinical applications based on surgical and market metrics .
-
Design and execute Clinical Strategy for First Indication (Reconstructive Surgery) with internal and external stakeholders, from First-in-human (MDD/MDR) to PMCF (MDD/MDR) and FDA study design.
Neurotech
-
Strategic Development of New Indication, reporting to CEO.
-
Development of new therapies in psychiatry, neurology and neuromodulation.
-
Support of the strategic choice of indication and development of a new indication of an implantable neurotechnology.
-
Market sizing and reimbursement analysis by geography and indication.
-
Strategic KOL network development.
-
Development of Business Case for investment in developing the indication.
-
Clinical study design, development, submission and approval in collaboration with CRO and KOLs.
-
Device design and development from concept through to V&V with internal R&D team and external suppliers.